|
[1]
|
Siegel, R., Naishadham, D. and Jemal, A. (2012) Cancer Statistics for Hispanics/Latinos, 2012. CA: A Cancer Journal for Clinicians, 62, 283-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Antoni, S., Ferlay, J., Soerjomataram, I., Znaor, A., Jemal, A. and Bray, F. (2017) Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. European Urology, 71, 96-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Ghanem, N. (2002) Haematuria Investigation Based on a Stand-ard Protocol: Emphasis on the Diagnosis of Urological Malignancy. Journal of the Royal College of Surgeons of Edin-burgh, 47, 772.
|
|
[4]
|
Marszalek, M., Wehrberger, C., Temml, C., Ponholzer, A., Berger, I. and Madersbacher, S. (2009) Chronic Pelvic Pain and Lower Urinary Tract Symptoms in Both Sexes: Analysis of 2749 Participants of an Urban Health Screening Project. European Urology, 55, 499-508. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kaufman, D.S., Shipley, W.U. and Feldman, A.S. (2009) Blad-der Cancer. Lancet, 374, 239-249. [Google Scholar] [CrossRef]
|
|
[6]
|
Shephard, E.A., Stapley, S., Neal, R.D., Rose, P., Walter, F.M. and Hamilton, W.T. (2012) Clinical Features of Bladder Cancer in Primary Care. British Journal of General Prac-tice, 62, e598-e604. [Google Scholar] [CrossRef]
|
|
[7]
|
Zhou, J., Kelsey, K.T., Smith, S., Giovannucci, E. and Michaud, D.S. (2015) Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results from the Health Professionals Fol-low-Up Study. Urology, 85, 1312-1318. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Isikay, L., Akgül, K.T., Nuhoğlu, B., Özdemir, G., Ayyıldız, A., Çavumirza, T. and Germiyanoğlu, C. (2007) Lower Urinary Tract Symptoms, Prostate Volume, Uroflowmetry, Residual Urine Volume and Bladder Wall Thickness in Turkish Men: A Comparative Analysis. International Urology and Neph-rology, 39, 1131-1135. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Moyer, V.A. and Force, U.S.P.S.T. (2011) Screening for Bladder Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 155, 246-251. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Vasekar, M., Degraff, D. and Joshi, M. (2016) Immunotherapy in Bladder Cancer. Current Molecular Pharmacology, 9, 242-251. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Goldberg, R.P., Sherman, W. and Sand, P.K. (2008) Cystoscopy for Lower Urinary Tract Symptoms in Urogynecologic Practice: The Likelihood of Finding Bladder Cancer. International Urogynecology Journal, 19, 991-994. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
van der Meijden, A., et al. (1999) Significance of Bladder Biop-sies in Ta,T1 Bladder Tumors: A Report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. European Urology, 35, 267-271. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Faiena, I., Rosser, C.J., Chamie, K. and Furuya, H. (2019) Diagnostic Biomarkers in Non-Muscle Invasive Bladder Cancer. World Journal of Urology, 37, 2009-2016. [Google Scholar] [CrossRef] [PubMed]
|